Literature DB >> 1658355

Interaction of a cellular 57-kilodalton protein with the internal translation initiation site of foot-and-mouth disease virus.

N Luz1, E Beck.   

Abstract

A cellular 57-kDa protein (p57) that binds specifically to the internal translation initiation site in the 5' untranslated region of foot-and-mouth disease virus RNA was detected in cell extracts of different mammalian species by UV cross-linking. The protein binds to two distinct sites of the translation control region which have as the only common sequence a UUUC motif. The first binding site consists of a conserved hairpin structure, whereas the second binding site contains an essential pyrimidine-rich region without obvious secondary structure. Competition experiments indicate that the complexes with the two binding sites were formed by a single p57 species. The protein binds also to the 5' untranslated region of other picornaviruses. Results from footprint analyses with foot-and-mouth disease RNA suggest the participation of additional cellular factors in the translation initiation complex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658355      PMCID: PMC250694     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

Review 1.  The novel mechanism of initiation of picornavirus RNA translation.

Authors:  R J Jackson; M T Howell; A Kaminski
Journal:  Trends Biochem Sci       Date:  1990-12       Impact factor: 13.807

2.  Cell proteins bind to multiple sites within the 5' untranslated region of poliovirus RNA.

Authors:  R M del Angel; A G Papavassiliou; C Fernández-Tomás; S J Silverstein; V R Racaniello
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  All foot and mouth disease virus serotypes initiate protein synthesis at two separate AUGs.

Authors:  D V Sangar; S E Newton; D J Rowlands; B E Clarke
Journal:  Nucleic Acids Res       Date:  1987-04-24       Impact factor: 16.971

4.  Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase.

Authors:  S van der Werf; J Bradley; E Wimmer; F W Studier; J J Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

5.  Binding sites of the 19-kDa and 68/72-kDa signal recognition particle (SRP) proteins on SRP RNA as determined in protein-RNA "footprinting".

Authors:  V Siegel; P Walter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation.

Authors:  S K Jang; H G Kräusslich; M J Nicklin; G M Duke; A C Palmenberg; E Wimmer
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  Comparative sequence analysis of the 5' noncoding region of the enteroviruses and rhinoviruses.

Authors:  V M Rivera; J D Welsh; J V Maizel
Journal:  Virology       Date:  1988-07       Impact factor: 3.616

8.  Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein.

Authors:  S K Jang; E Wimmer
Journal:  Genes Dev       Date:  1990-09       Impact factor: 11.361

9.  Initiation of protein synthesis by internal entry of ribosomes into the 5' nontranslated region of encephalomyocarditis virus RNA in vivo.

Authors:  S K Jang; M V Davies; R J Kaufman; E Wimmer
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

10.  Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA.

Authors:  J Pelletier; N Sonenberg
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

View more
  66 in total

1.  La autoantigen enhances translation of BiP mRNA.

Authors:  Y K Kim; S H Back; J Rho; S H Lee; S K Jang
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

2.  Translation of polioviral mRNA is inhibited by cleavage of polypyrimidine tract-binding proteins executed by polioviral 3C(pro).

Authors:  Sung Hoon Back; Yoon Ki Kim; Woo Jae Kim; Sungchan Cho; Hoe Rang Oh; Jung-Eun Kim; Sung Key Jang
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

3.  Computational modeling of eukaryotic mRNA turnover.

Authors:  D Cao; R Parker
Journal:  RNA       Date:  2001-09       Impact factor: 4.942

4.  Structural organization of a viral IRES depends on the integrity of the GNRA motif.

Authors:  Olga Fernández-Miragall; Encarnación Martínez-Salas
Journal:  RNA       Date:  2003-11       Impact factor: 4.942

5.  Internal entry of ribosomes on a tricistronic mRNA encoded by infectious bronchitis virus.

Authors:  D X Liu; S C Inglis
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

Review 6.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  Functional involvement of polypyrimidine tract-binding protein in translation initiation complexes with the internal ribosome entry site of foot-and-mouth disease virus.

Authors:  M Niepmann; A Petersen; K Meyer; E Beck
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

8.  Comparative analysis of the large fragment of the 5' untranslated region (LF-5' UTR) of serotype A foot-and-mouth disease virus field isolates from India.

Authors:  Jajati K Mohapatra; Abhipsa Sahu; Sushanta K Barik; Aniket Sanyal; Bramhadev Pattnaik
Journal:  Virus Genes       Date:  2009-05-15       Impact factor: 2.332

9.  Cell proteins bind to a linear polypyrimidine-rich sequence within the 5'-untranslated region of rhinovirus 14 RNA.

Authors:  I A Rojas-Eisenring; M Cajero-Juarez; R M del Angel
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Identification and characterization of a cis-acting replication element (cre) adjacent to the internal ribosome entry site of foot-and-mouth disease virus.

Authors:  Peter W Mason; Svetlana V Bezborodova; Tina M Henry
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.